Amgen Senior VP-Research and Development Joseph Miletich: An Interview With “The Pink Sheet” DAILY (Part 2 of 3)
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec discusses his views on biogenerics and Amgen's development program for the novel monoclonal antibody denosumab.
You may also be interested in...
Amgen Senior VP-Research and Development Joseph Miletich: An Interview With “The Pink Sheet” DAILY (Part 3 of 3)
Miletich discusses the firm’s peptibody candidates in therapeutic areas including autoimmune diseases and oncology.
Amgen Senior VP-Research and Development Joseph Miletich: An Interview With “The Pink Sheet” DAILY (Part 3 of 3)
Miletich discusses the firm’s peptibody candidates in therapeutic areas including autoimmune diseases and oncology.
Amgen Senior VP-Research and Development Joseph Miletich: An Interview With “The Pink Sheet” DAILY (Part 1 of 3)
Exec discusses Amgen’s drug development strategy and pipeline and his concerns regarding follow-on biologics, personalized medicine and other issues.